Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) EBT (2017 - 2025)

Catheter Precision (VTAK) has disclosed EBT for 9 consecutive years, with -$6.1 million as the latest value for Q4 2025.

  • Quarterly EBT fell 143.75% to -$6.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$19.5 million through Dec 2025, down 44.46% year-over-year, with the annual reading at -$19.5 million for FY2025, 44.46% down from the prior year.
  • EBT for Q4 2025 was -$6.1 million at Catheter Precision, down from -$2.3 million in the prior quarter.
  • The five-year high for EBT was -$669000.0 in Q4 2023, with the low at -$66.4 million in Q1 2023.
  • Average EBT over 5 years is -$7.9 million, with a median of -$5.0 million recorded in 2021.
  • The sharpest move saw EBT tumbled 1108.37% in 2023, then skyrocketed 95.97% in 2024.
  • Over 5 years, EBT stood at -$8.3 million in 2021, then rose by 1.53% to -$8.2 million in 2022, then skyrocketed by 91.8% to -$669000.0 in 2023, then tumbled by 271.75% to -$2.5 million in 2024, then crashed by 143.75% to -$6.1 million in 2025.
  • According to Business Quant data, EBT over the past three periods came in at -$6.1 million, -$2.3 million, and -$6.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.